Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes of immune-related factors in the blood of schizophrenia and bipolar disorder patients receiving monotherapy.

Translational psychiatry - 26 May 2022

Duan Fangyuan, Zhao Shunan, Xia Cuihua, Ren Zongyao, Yuan Ning, Xie Li, Wang Le, Xiong Yifan, Yu Pei, Chen Yu, Tian Jianghua, Dai Jiacheng, Lu Jiaqi, Xia Yan, Liu Xuejun, Chen Chao, Liu Chunyu

Abstract excerpt

Schizophrenia (SCZ) and bipolar disorder (BPD) are associated with abnormal expression of immune-related factors (IRFs), which have been proposed as biomarkers of either disease diagnosis (trait markers) or treatment (state markers). However, the state markers have been found to be less reproducible than the trait markers in previous studies. In the current study, we focused on the changes of IRFs in blood of SCZ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bipolar Disorder

Share to Phenotype

Share to Psychotic Disorders

Share to Schizophrenia

Source

Open in PubMed Open full text

Identifiers

PMID: 35618730
DOI: 10.1038/s41398-022-01968-0
PMCID: PMC9135722

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes of immune-related factors in the blood of schizophrenia and bipolar disorder patients receiving monotherapy.PMID 35618730Read ↗

B Cell-activating factor (BAFF): A promising trans-nosographic biomarker of inflammation and autoimmunity in bipolar disorder and schizophrenia.Semantic proximity Read ↗

Patients with schizophrenia and bipolar disorder display a similar global gene expression signature in whole blood that reflects elevated proportion of immature neutrophil cells with association to lipid changesSemantic proximity Read ↗

Altered levels of cytokine, T- and B-lymphocytes, and PD-1 expression rates in drug- naïve schizophrenia patients with acute phaseSemantic proximity Read ↗

A diagnostic model based on bioinformatics and machine learning to differentiate bipolar disorder from schizophrenia and major depressive disorderSemantic proximity Read ↗

Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysis.Semantic proximity Read ↗

In Schizophrenia, Depression and Anxiety Symptoms Are Driven by Immune-Inflammatory Pathways.Semantic proximity Read ↗

Limited association between infections, autoimmune disease and genetic risk and immune activation in severe mental disorders.Semantic proximity Read ↗

Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder.Semantic proximity Read ↗

MicroRNAs and pro-inflammatory cytokines as candidate biomarkers for recent-onset psychosisSemantic proximity Read ↗

Involvement of CXCL10 rs4256246, CXCR4 rs2228014, CCR2 rs1799864 and CXCL16 rs2277680 in the Predisposition to Schizophrenia.Semantic proximity Read ↗

The value of interleukin 6 as a peripheral diagnostic marker in schizophreniaSemantic proximity Read ↗

Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.